Wide Ranks

IOBT

IO Biotech, Inc.

0.8500

Top Statistics
Market Cap 55 M Forward PE -0.6606 Revenue Growth 0.00 %
Current Ratio 7.84 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.3720 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 100 M Total Cash Per Share 1.53 Total Debt 2 M
Total Debt To Equity 2.23 Current Ratio 7.84 Book Value Per Share 2.02
All Measures
Short Ratio 189.00 % Message Board Id finmb_1685354464 Shares Short Prior Month 317530
Return On Equity -0.8766 City Copenhagen Uuid ea2848e4-aa90-3bf4-82a5-9ce691c6a8c0
Previous Close 0.7480 First Trade Date Epoch Utc 1 B Book Value 2.02
Beta 0.4190 Total Debt 2 M Volume 787014
Price To Book 0.4206 Fifty Two Week Low 0.6600 Total Cash Per Share 1.53
Shares Short Previous Month Date 1 B Target Median Price 9.00 Max Age 86400
Sand P52 Week Change 0.3133 Target Mean Price 9.00 Net Income To Common -88004000
Short Percent Of Float 0.0083 Implied Shares Outstanding 65 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 967280 Average Volume10days 967280
Total Cash 100 M Next Fiscal Year End 1 B Held Percent Insiders 0.0024
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 0.7480 Target Low Price 6.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 1.07 Open 0.7400 Free Cashflow -51137124
Dividend Yield 0.00 % Return On Assets -0.5098 Time Zone Short Name EST
Trailing Eps -1.29 Day Low 0.7210 Address1 Ole Maaløes Vej 3
Shares Outstanding 65 M Price Hint 4 Target High Price 12.00
Website https://www.iobiotech.com 52 Week Change -0.2735 Average Volume 594934
Forward Eps -1.17 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 741.70 % Is_sp_500 False Regular Market Day High 0.8700
Profit Margins 0.00 % Debt To Equity 2.23 Fifty Two Week High 2.10
Day High 0.8700 Shares Short 200923 Regular Market Open 0.7400
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0031 Operating Cashflow -80699000 Currency USD
Time Zone Full Name America/New_York Market Cap 55 M Is_nasdaq_100 False
Zip 2200 Quote Type EQUITY Industry Biotechnology
Long Name IO Biotech, Inc. Regular Market Day Low 0.7210 Held Percent Institutions 0.7679
Current Price 0.8500 Address2 Copenhagen N Enterprise To Ebitda 0.3720
Financial Currency USD Current Ratio 7.84 Industry Disp Biotechnology
Number Of Analyst Opinions 4 Country Denmark Float Shares 27 M
Two Hundred Day Average 1.32 Enterprise Value -34685924 Forward PE -0.6606
Regular Market Volume 787014 Ebitda -93157000 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform.

The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive mechanisms mediated by Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, bladder, and melanoma cancer.

It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers.

The company was incorporated in 2014 and is based in Copenhagen, Denmark.